CGC
NYSECanopy Growth Corporation
SectorHealth CareIndustry Medicinal Chemicals and Botanical Products
News · 26 weeks37+75%
2025-10-262026-04-19
Mix1890d
- SEC Filings6(33%)
- Insider5(28%)
- Other3(17%)
- Leadership3(17%)
- Analyst1(6%)
Latest news
25 items- PR'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer CampaignNew window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro
- INSIDERSEC Form 4 filed by Yanofsky Theresa4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERSEC Form 4 filed by Atkins M Shan4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERSEC Form 4 filed by Bayern Joseph4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERSEC Form 4 filed by Lazzarato David Angelo4 - Canopy Growth Corp (0001737927) (Issuer)
- PRCanopy Growth Unveils New Brand 'Deelish': High THC, Everyday Price27%-33% THC flower, and 26%-32% THC pre-rolls across rotating genetics Now available at select stores across Ontario and Alberta Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the everyday consumer with an everyday price. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331523789/en/High THC, Everyday Price. Deelish is Canopy Growth's newest brand, delivering high THC with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. Deelish enters the market built to deliver high THC with flower testing at 27%-33% THC a
- PRCanopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis ClinicVoted best by Toronto Star Readers' Choice Awards Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced that its Apollo Cannabis Clinics ("Apollo") has been named Best Medical Cannabis Clinic in the 2025 Toronto Star's Readers' Choice Awards, a public vote that reflects the trust patients place in Apollo's care. Apollo represents the Company's commitment to raising the standard of medical cannabis and making quality treatment accessible to every Canadian. "This recognition comes directly from the people we care for, and that makes it especially meaningful," said Luc Mongeau, Chief Executive Officer of Canopy Growth. "Everything Apollo doe
- ANALYSTCanaccord Genuity initiated coverage on Canopy GrowthCanaccord Genuity initiated coverage of Canopy Growth with a rating of Buy
- PRCanopy Growth Announces Storz & Bickel Executive TransitionDavid Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into a global premium vaporization technology leader, passes the torch following 25 years of transformational leadership Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization technology. Today, it sets the standard for innovation, p
- SECCanopy Growth Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By RevenueThis news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Strengthens Canopy Growth's core Canadian platform, providing additional high-quality flower to support international growth Expected run-rate synergies of approximately $10 million within 18 months Canopy Growth's leadership team and operational depth strengthened through addition of MTL management team members Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) and MTL Cannab
- PRCanopy Growth Announces MTL Cannabis Shareholder Approval of AcquisitionCanopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce that shareholders of MTL Cannabis Corp. ("MTL Cannabis" or "MTL") have voted to approve the Company's previously announced acquisition of MTL (the "Transaction") at a special meeting of shareholders of MTL (the "MTL Shareholders") held February 17, 2026. The plan of arrangement with Canopy Growth received overwhelming support from MTL Shareholders, with (i) 99.97% of all shares of MTL (the "MTL Shares") cast in favour of the special resolution approving the Transaction, and (ii) 99.80% of MTL Shares, excluding votes attached to MTL Shares required to be excluded pursuant to Multilat
- SECSEC Form EFFECT filed by Canopy Growth CorporationEFFECT - Canopy Growth Corp (0001737927) (Filer)
- SECSEC Form 424B3 filed by Canopy Growth Corporation424B3 - Canopy Growth Corp (0001737927) (Filer)
- INSIDERChief Executive Officer Mongeau Luc sold $9,951 worth of shares (9,376 units at $1.06), decreasing direct ownership by 1% to 802,992 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- SECSEC Form S-3 filed by Canopy Growth CorporationS-3 - Canopy Growth Corp (0001737927) (Filer)
- SECCanopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- SECSEC Form 10-Q filed by Canopy Growth Corporation10-Q - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2026 ended December 31, 2025 before financial markets open on February 6, 2026. Following the release of its third quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on February 6, 2026 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=45C34153-5530-4D6A-A742-BC34AD2534FA Replay Information A replay will be accessible by webcast until 11:59 PM ET on May 7, 2026 at:
- PR2026 Asset Growth: Why Federal Compliance Is the New MetricVANCOUVER, British Columbia, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Consumer healthcare markets hit a massive $362 billion entering 2026, but smart money is shifting toward regulatory certainty rather than just market size[1]. Modern health organizations are using aggressive buyouts as a primary 2026 strategy to secure high-tech efficiency while navigating intense federal scrutiny and capital limits[2]. In this high-stakes environment, companies with a clear and proven path through federal guidelines are capturing the most attention, including Doseology Sciences Inc. (CSE:MOOD) (OTCPK:DOSEF) (FSE: VU70), Canopy Growth (NASDAQ:CGC) (TSX:WEED), Definium Therap
- SECSEC Form EFFECT filed by Canopy Growth CorporationEFFECT - Canopy Growth Corp (0001737927) (Filer)
- SECSEC Form 424B3 filed by Canopy Growth Corporation424B3 - Canopy Growth Corp (0001737927) (Filer)
- SECSEC Form S-3 filed by Canopy Growth CorporationS-3 - Canopy Growth Corp (0001737927) (Filer)
- SECCanopy Growth Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth StrategyThis news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 Refinances Term Loan due 2027 and Exchanges Convertible Debentures due 2029, Extending Maturities of All Outstanding Indebtedness to Earliest January 2031 While Enhancing Liquidity Profile Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has entered into a series of transactions to recapitalize its balance sheet and extend the ma